1. Authors/Task Force Members: C, A.L., Graham, I., De Backer, G., Wiklund, O., Chapman, M.J., Drexel, H, Hoes, A.W., Jennings, C.S., Landmesser, U., Pedersen, T.R., Reiner, Ž., Riccardi, G., Taskinen, M.R., Tokgozoglu, L., Verschuren, W.M., Vlachopoulos, C., Wood, D.A., Zamorano, J.L. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR) Atherosclerosis. 2016(253):281–344.
2. Aboyans V, Björck, M., Brodmann, M., Collet, J.P., Czerny, M., De Carlo, M., Naylor, A.R., Roffi, M., Tendera, M., Vlachopoulos, C., Ricco, J.B., ESC Scientific Document Group. Questions and answers on diagnosis and management of patients with peripheral arterial diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO). The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018(55):457–64.
3. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–504.
4. Dembowski E, Davidson MHA. Review of lipid management in primary and secondary prevention. J Cardiopulm Rehabil Prev. 2009;29(1):2–12.
5. Molnár G, Dagher MC, Geiszt M, Settleman J, Ligeti E. Role of prenylation in the interaction of Rho-family small GTPases with GTPase activating proteins. Biochemistry. 2001;40(35):10542–9.